These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 29861163

  • 1. Investigation of grey matter abnormalities in multiple sclerosis patients by combined use of double inversion recovery sequences and diffusion tensor MRI at 3.0 Tesla.
    Han X, Wang X, Wang L, Zheng Z, Gu J, Tang D, Liu L, Liu S.
    Clin Radiol; 2018 Sep; 73(9):834.e17-834.e23. PubMed ID: 29861163
    [Abstract] [Full Text] [Related]

  • 2. Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study.
    Calabrese M, Rinaldi F, Seppi D, Favaretto A, Squarcina L, Mattisi I, Perini P, Bertoldo A, Gallo P.
    Radiology; 2011 Dec; 261(3):891-8. PubMed ID: 22031708
    [Abstract] [Full Text] [Related]

  • 3. Characteristics of lesional and extra-lesional cortical grey matter in relapsing-remitting and secondary progressive multiple sclerosis: A magnetisation transfer and diffusion tensor imaging study.
    Yaldizli Ö, Pardini M, Sethi V, Muhlert N, Liu Z, Tozer DJ, Samson RS, Wheeler-Kingshott CA, Yousry TA, Miller DH, Chard DT.
    Mult Scler; 2016 Feb; 22(2):150-9. PubMed ID: 26014608
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC, Gold SM, Lee B, Montag M, Horsfall J, O'Connor MF, Sicotte NL.
    Neuroimage Clin; 2015 Feb; 8():440-7. PubMed ID: 26106524
    [Abstract] [Full Text] [Related]

  • 6. Diffusion tensor imaging abnormalities in cognitively impaired multiple sclerosis patients.
    Akbar N, Lobaugh NJ, O'Connor P, Moradzadeh L, Scott CJ, Feinstein A.
    Can J Neurol Sci; 2010 Sep; 37(5):608-14. PubMed ID: 21059506
    [Abstract] [Full Text] [Related]

  • 7. Diffusion tensor imaging in early relapsing-remitting multiple sclerosis.
    Griffin CM, Chard DT, Ciccarelli O, Kapoor B, Barker GJ, Thompson AI, Miller DH.
    Mult Scler; 2001 Oct; 7(5):290-7. PubMed ID: 11724444
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. DT MRI microstructural cortical lesion damage does not explain cognitive impairment in MS.
    Preziosa P, Pagani E, Morelli ME, Copetti M, Martinelli V, Pirro F, Falini A, Comi G, Filippi M, Rocca MA.
    Mult Scler; 2017 Dec; 23(14):1918-1928. PubMed ID: 28098510
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of patients with relapsing-remitting multiple sclerosis using tract-based spatial statistics analysis: diffusion kurtosis imaging.
    Li HQ, Yin B, Quan C, Geng DY, Yu H, Bao YF, Liu J, Li YX.
    BMC Neurol; 2018 Aug 07; 18(1):108. PubMed ID: 30086721
    [Abstract] [Full Text] [Related]

  • 12. Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration.
    Vrenken H, Pouwels PJ, Geurts JJ, Knol DL, Polman CH, Barkhof F, Castelijns JA.
    J Magn Reson Imaging; 2006 May 07; 23(5):628-36. PubMed ID: 16565955
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study.
    Zivadinov R, Bergsland N, Hagemeier J, Tavazzi E, Ramasamy DP, Durfee J, Cherneva M, Carl E, Carl J, Kolb C, Hojnacki D, Weinstock-Guttman B.
    J Neurol Sci; 2018 Apr 15; 387():152-156. PubMed ID: 29571854
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Normal appearing white matter permeability: a marker of inflammation and information processing speed deficit among relapsing remitting multiple sclerosis patients.
    Eftekhari E, Hojjat SP, Vitorino R, Carroll TJ, Cantrell CG, Lee L, Taylor MW, Morrow SA, Benhabib H, Aviv RI, Kassner A.
    Neuroradiology; 2017 Aug 15; 59(8):771-780. PubMed ID: 28623483
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.